Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
17.24
-0.42 (-2.35%)
At close: Apr 4, 2025, 4:00 PM
17.01
-0.23 (-1.31%)
After-hours: Apr 4, 2025, 7:58 PM EDT

Rigel Pharmaceuticals Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Rigel Pharmaceuticals stock have an average target of 36.8, with a low estimate of 23 and a high estimate of 57. The average target predicts an increase of 113.46% from the current stock price of 17.24.

Analyst Consensus: Buy
Target Low Average Median High
Price $23 $36.8 $25 $57
Change +33.41% +113.46% +45.01% +230.63%
* Price targets were last updated on Mar 6, 2025.

Analyst Ratings

The average analyst rating for Rigel Pharmaceuticals stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 222222
Buy 000000
Hold 333333
Sell 000000
Strong Sell 000000
Total 555555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Citigroup
Citigroup
Strong Buy
Maintains
$49$55
Strong Buy Maintains $49$55 +219.03% Mar 6, 2025
B. Riley Securities
B. Riley Securities
Hold
Maintains
$20$24
Hold Maintains $20$24 +39.21% Mar 5, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$57
Strong Buy Reiterates $57 +230.63% Mar 5, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$57
Strong Buy Reiterates $57 +230.63% Jan 23, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$57
Strong Buy Reiterates $57 +230.63% Jan 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
201.74M
from 179.28M
Increased by 12.53%
Revenue Next Year
233.37M
from 201.74M
Increased by 15.68%
EPS This Year
1.06
from 0.99
Increased by 7.07%
EPS Next Year
1.76
from 1.06
Increased by 66.44%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
108.62M138.74M115.74M115.88M179.28M201.74M233.37M266.73M
Revenue Growth
83.21%27.73%-16.57%0.12%54.71%12.53%15.68%14.29%
EPS
-1.76-1.05-3.44-1.440.991.061.763.51
EPS Growth
-----7.07%66.44%99.22%
Forward PE
-----16.269.774.90
No. Analysts -----887
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 215.6M 250.7M 294.0M
Avg 201.7M 233.4M 266.7M
Low 185.0M 211.4M 242.6M

Revenue Growth

Revenue Growth 20252026202720282029
High
20.2%
24.3%
26.0%
Avg
12.5%
15.7%
14.3%
Low
3.2%
4.8%
3.9%

EPS Forecast

EPS 20252026202720282029
High 1.39 3.45 6.03
Avg 1.06 1.76 3.51
Low 0.69 0.66 1.13

EPS Growth

EPS Growth 20252026202720282029
High
40.0%
225.8%
241.7%
Avg
7.1%
66.4%
99.2%
Low
-30.7%
-38.1%
-36.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.